Overview

Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo

Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Vitiligo is a common acquired, depigmenting skin disease that affect the patient's psychological state and quality of life.
Phase:
Phase 4
Details
Lead Sponsor:
Assiut University
Treatments:
Fluorouracil
Methotrexate